Prossimo Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-376
Closed -$218K 39
2025
Q4
$218K Buy
+376
New +$213K 1.4% 30
2025
Q3
Sell
-1,143
Closed -$463K 116
2025
Q2
$463K Sell
1,143
-512
-31% -$214K 0.37% 75
2025
Q1
$824K Sell
1,655
-37
-2% -$20K 0.62% 48
2024
Q4
$880K Sell
1,692
-115
-6% -$63.2K 0.64% 44
2024
Q3
$1.12M Buy
1,807
+12
+0.7% +$7.1K 0.82% 29
2024
Q2
$993K Buy
+1,795
New +$1.03M 0.9% 29
2023
Q3
Sell
-1,685
Closed -$879K 117
2023
Q2
$879K Buy
+1,685
New +$909K 0.85% 31

Other funds holding TMO

Prossimo Advisors's TMO Position: Q1 2026 in Review

Prossimo Advisors sold out of Thermo Fisher Scientific (TMO) in Q1 2026, closing a stake of 376 shares — an estimated $218K sold.

Prossimo Advisors first reported a position in TMO in Q2 2023 and held it in 7 quarters. The position peaked at $1.12M in Q3 2024. 2,590 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Prossimo Advisors reported no remaining Thermo Fisher Scientific position as of Q1 2026 after selling out during the quarter.
  • Prossimo Advisors sold 376 Thermo Fisher Scientific shares in Q1 2026, an estimated $218K.
  • Prossimo Advisors first reported a position in Thermo Fisher Scientific in Q2 2023 and held it in 7 quarters.
  • Prossimo Advisors's Thermo Fisher Scientific position peaked at $1.12M in Q3 2024.
  • 2,590 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Prossimo Advisors's 13F filing for Q1 2026, filed 29 Apr 2026.